Seroprevalence and Associated Risk Factors of HBV Co-infection Among HIV Infected Children Enrolled into Care at Kilimanjaro Christian Medical Centre, Tanzania
Volume 3, Issue 6, December 2015, Pages: 324-328
Received: Oct. 29, 2015;
Accepted: Nov. 16, 2015;
Published: Dec. 10, 2015
Views 3781 Downloads 133
Rose H. Mende, Department of Paediatrics and Child Health, Kilimanjaro Christian Medical Centre, Moshi, Tanzania; Kilimanjaro Christian Medical University College, Tumaini University Makumira, Moshi, Tanzania; Department of Paediatrics and Child Health, Mount Meru Regional Referral Hospital, Arusha, Tanzania
Blandina T. Mmbaga, Department of Paediatrics and Child Health, Kilimanjaro Christian Medical Centre, Moshi, Tanzania; Kilimanjaro Christian Medical University College, Tumaini University Makumira, Moshi, Tanzania; Kilimanjaro Clinical Research Institute, Moshi, Tanzania; Division of Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA
Rahim K. Damji, Department of Paediatrics and Child Health, Kilimanjaro Christian Medical Centre, Moshi, Tanzania; Kilimanjaro Christian Medical University College, Tumaini University Makumira, Moshi, Tanzania
Ben C. J. Hamel, Radboud University Medical Center, Nijmegen, the Netherlands
Ann M. Buchanan, Division of Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA; Duke Global Health Institute, Duke University, Durham, North Carolina, USA
Sub-Saharan Africa remains the region most affected with HIV. The wide use of highly active anti-retroviral therapy has led to improvement in life expectancy among HIV infected individuals. However, hepatitis B virus related complications like liver cirrhosis and liver failure are now becoming common causes of morbidity and mortality in this group. The aim of this study was to determine the seroprevalence and risk factors of HBV/HIV co-infection among HIV infected children enrolled into care at Kilimanjaro Christian Medical Centre (KCMC). This cross sectional analytical study was conducted among 323 HIV infected children at KCMC between February 2013 and May 2013. Investigations included interviews, physical examination and HBsAg analysis. HIV serostatus and CD4 counts/percentages were obtained from patients records. In addition, information on hepatitis vaccine status was recorded. Among 323 HIV-infected children enrolled, 177 (54.8%) were males. The prevalence of hepatitis B virus and HIV co-infection was found to be 1.2% (n=4). Hepatitis B virus co-infection was not significantly associated with any of the sociodemographic or behaviour risk factors which were assessed. CD4 counts were significantly associated with hepatitis B virus status whereby children with CD4 counts less than 350 cells/mm3 were 14 times more likely to have hepatitis B virus co- infection as compared to those who had CD4 counts greater than 350 cells/mm3. All of the hepatitis B virus co-infected children had no records of hepatitis B virus immunization, though one was born during the period of universal infant’s hepatitis B vaccination (<4 years old). The frequency of hepatitis B virus co-infection with HIV infection was low among HIV infected children in our set up. It is important to strengthen the implementation of the universal infant’s hepatitis B virus vaccination. The screening of HIV infected children for hepatitis B virus co-infection is still important whenever possible with immunization of all HIV infected children and adolescents with negative HBsAg.
Rose H. Mende,
Blandina T. Mmbaga,
Rahim K. Damji,
Ben C. J. Hamel,
Ann M. Buchanan,
Seroprevalence and Associated Risk Factors of HBV Co-infection Among HIV Infected Children Enrolled into Care at Kilimanjaro Christian Medical Centre, Tanzania, Science Research.
Vol. 3, No. 6,
2015, pp. 324-328.
Komas NP, Baï-sepou S, Manirakiza A, Léal J, Béré A, Faou AL. The prevalence of hepatitis B virus markers in a cohort of students in Bangui , Central African Republic. BMC Infes Dis 2010; 10: 226.
UNAIDS: 2012 Report on Global AIDS epidemic. Availlable at http://www.unaids.org/en/regionscountries/countries/unitedrepublicoftanzania/ accessed on 16/06/2013
Firnhaber CS, Ive P. Hepatitis B and HIV co-infection in South Africa: just treat it. S Afr J HIV Med 2009; 10: 10–14.
Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD. Hepatitis B and HIV prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19(6): 593-601.
Telatela SP, Matee MI, Munubhi EK. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania. BMC Public Health 2007; 7: 338-43.
Muro FJ, Fiorillo SP, Sakasaka P, Odhiambo C, Reddy EA, Cunningham CK, Buchanan AM. Seroprevalence of Hepatitis B ad C Viruses Among Children in Kilimanjaro Region, Tanzania. J Pediatr Infect Dis Soc 2013; 2(4): 1-7.
Hutchison R. Children & neonates. In Hutchison's clinical methods 21st edition. edited by: Swash M. London: Royal Hospital; 2002: 376-86.
Abera B, Zenebe Y, Mulu W, Kibret M, Kahsu G. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia. BMC Res Notes 2014; 7: 838.
Sadoh AE, Sadoh WE, Iduoriyekemwen NJ. HIV co-infection with hepatitis B and C viruses among Nigerian children in an antiretroviral treatment programme. S Afr J Child Health 2011; 5(1): 7–10.
Rouet F, Chaix ML, Inwoley A, Anaky MF, Fassinou P, Kpozehouen A, Rouzioux C, Blanche S, Msellati P. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children. J Clin Infect Dis 2008; 46: 361–6.
Peebles K, Nchimba L, Chilengi R, Bolton Moore C, Mubiana-Mbewe M, Vinikoor MJ. Pediatric HIV-HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes. J Trop Pediatr 2015. [Epub ahead of print]
Bhargava A, Singh DK, Rai R. Sero-prevalence of viral co-infections in HIV infected children of Northern India. Indian J Pediatr 2009; 76(9): 917–9.
Zhou S, Zhao Y, He Y, Li H, Bulterys M, Sun X, Dou Z, Robinson M, Zhang F. Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009. J Acq Immun Def Synd 2010; 54(2): 191-6.
François G, Dochez C, Mphahlele MJ, Burnett R, Hala GV, Meheus A. Hepatitis B vaccination in Africa: mission accomplished? S Afr J Epid Infect 2008; 23(1): 24-8.
Nwolisa E, Mbanefo F, Ezeogu J, Amadi P. Prevalence of Hepatitis B co-infection amongst HIV infected children attending a care and treatment centre in Owerri, south-eastern Nigeria. Pan Afr Med J 2013; 14: 89-93.
Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankale J, Ekong E, Murphy R, Kanki P, Thio CL. Impact of Hepatitis B Virus Infection on Human Immunodeficiency Virus Response to Antiretroviral Therapy in Nigeria. J Clin Infect Dis 2009; 49: 1268–73.
Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009; 9(5): S138–45.
Anigilaje EA, Olutola A. Prevalence and Clinical and Immunological Profile of Human Immunodeficiency Virus-Hepatitis B Co-infection among Children in an Antiretroviral Therapy Programme in Benue State, Nigeria. ISRN Pediatr 2013, 932697. doi: 10.1155/2013/932697932697.
Andersson MI, Preiser W, Van Rensburg C, Taljaard J, Hoffmann CJ. Editorial. The HIV/HBV co-infected patient: Time for proactive management. S Afr Med J 2015; 105(4): 281-2.